High Tower Advisors, LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 11, 2023	BUY	$8.36 - $11.37 $150,480 - $204,660	18,000 New	18,000 $159,000
Q2 2022 Aug 10, 2022	BUY	$7.38 - $10.4 $167,157 - $235,560	22,650 Added 6471.43%	23,000 $7,000
Q1 2022 May 12, 2022	SELL	$7.33 - $9.39 $950,334 - $1.22 Million	-129,650 Reduced 99.73%	350 $14,000
Q2 2021 Aug 06, 2021	BUY	$9.9 - $11.56 $1.28 Million - $1.49 Million	129,000 Added 12900.0%	130,000 $114,000
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $133,455 - $171,120	-15,500 Reduced 93.94%	1,000 $58,000
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $132,835 - $196,695	15,500 Added 1550.0%	16,500 $11,000
Q2 2020 Aug 10, 2020	SELL	$8.12 - $13.12 $73,080 - $118,080	-9,000 Reduced 90.0%	1,000 $1,000
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $32,650 - $53,600	5,000 Added 100.0%	10,000 $3,000
Q3 2018 Nov 09, 2018	BUY	$21.06 - $25.65 $84,240 - $102,600	4,000 Added 400.0%	5,000 $4,000
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $15,410 - $32,170	1,000	1,000 $1,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.